ArticleAmerican journal of clinical dermatology2026

Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial.

Ling Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.